Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors

Clinical trial NCT00602082 · COMPLETED

Trial details

NCT number: NCT00602082
Sponsor: Cambridge University Hospitals NHS Foundation Trust
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gastrointestinal Carcinoid Tumor Islet Cell Tumor

Start date: 2005-08-01
Primary completion: 2009-12-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.